Abstract
The GDP dissociation inhibitors (GDIs) are pivotal regulators of Rho GTPase function. GDIs control the access of Rho GTPases to regulatory guanine nucleotide exchange factors and GTPase-activating proteins, to effector targets and to membranes where such effectors reside. We discuss here our current understanding of how Rho GTPase-GDI complexes are regulated by various proteins, lipids and enzymes that exert GDI displacement activity. We propose that phosphorylation mediated by diverse kinases might provide a means of controlling and coordinating Rho GTPase activation.
MeSH terms
-
Animals
-
Enzyme Activators / pharmacology
-
Guanine Nucleotide Dissociation Inhibitors / metabolism*
-
Guanine Nucleotide Dissociation Inhibitors / physiology*
-
Guanine Nucleotide Exchange Factors / pharmacology
-
Humans
-
Lipids / pharmacology
-
Phosphorylation
-
Protein Kinases / metabolism*
-
Proteins / physiology
-
Tumor Suppressor Proteins
-
rab GTP-Binding Proteins / metabolism*
-
rho GTP-Binding Proteins / antagonists & inhibitors
-
rho GTP-Binding Proteins / chemistry
-
rho GTP-Binding Proteins / metabolism*
-
rho GTP-Binding Proteins / physiology
-
rho Guanine Nucleotide Dissociation Inhibitor gamma
-
rho-Specific Guanine Nucleotide Dissociation Inhibitors
Substances
-
ARHGDIG protein, human
-
Enzyme Activators
-
GDP dissociation inhibitor 1
-
Guanine Nucleotide Dissociation Inhibitors
-
Guanine Nucleotide Exchange Factors
-
Lipids
-
Proteins
-
Tumor Suppressor Proteins
-
rho Guanine Nucleotide Dissociation Inhibitor gamma
-
rho-Specific Guanine Nucleotide Dissociation Inhibitors
-
Protein Kinases
-
rab GTP-Binding Proteins
-
rho GTP-Binding Proteins